Education

Quinsigamond Community College in Worcester announced on Wednesday it will use funding from the Federal Higher Education Emergency Relief Fund to relieve college-held debt for students enrolled in credit degree or certificate programming between March 13, 2020 and through the end for the spring 2021 semester. 

To better represent its patient population, the board of directors at the Edward M. Kennedy Community Health Center has made an effort during the past three years to diversify and include a greater variety of perspectives under the leadership of chair Valerie Zolezzi-Wyndham.

A Worcester State University-hosted vaccine clinic run by Saint Vincent Hospital is closing June 10, after administering over 83,000 coronavirus vaccines, Saint Vincent announced on Thursday.

Nicholas Lazzaro, a student at the College of the Holy Cross in Worcester, founded his own automobile service business, Nick's On-Site Detailing, in order to put himself through college.

Worcester Polytechnic Institute has named Mimi Sheller, a professor and head of the department of Drexel University in Philadelphia, as the inaugural dean of The Global School, WPI announced on Wednesday.

This summer, Quinsigamond Community College in Worcester will offer a fully-funded administrative medical professional training program.

Nichols College in Dudley has scored Massachusetts 45/100 on the latest iteration of the school’s biennial Massachusetts Women’s Leadership Index, which is overseen by the college’s Institute for Women’s Leadership.

The board of trustees at the Nativity School of Worcester, an independent Jesuit middle school, announced the appointment of Thomas McKenney as the new president effective June 4.

The degree, part of the Strassler Center for Holocaust and Genocide Studies at Clark, will integrate fields like political science, anthropology, and pedagogy in studies of genocide across a global context. 

Early data in a trial, run in part at UMass Medical School in Worcester, for adolescents indicates the Moderna COVID-19 vaccine has a 95% efficacy with no serious safety concerns to date for individuals aged 12 to 17, as the pharmaceutical company works to receive approval for the vaccine’s widespread use in children.